Study Of PF-06817024 In Healthy Subjects, In Patients With Chronic Rhinosinusitis With Nasal Polyps And in Patients With Atopic Dermatitis
Public ClinicalTrials.gov record NCT02743871. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A PHASE 1, RANDOMIZED, DOUBLE-BLIND, THIRD-PARTY OPEN, PLACEBO-CONTROLLED, DOSE ESCALATING STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF SINGLE AND/OR MULTIPLE INTRAVENOUS AND/OR SUBCUTANEOUS DOSES OF PF-06817024 IN HEALTHY SUBJECTS WHO MAY BE MILDLY ATOPIC, SUBJECTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPS, AND SUBJECTS WITH MODERATE-SEVERE ATOPIC DERMATITIS
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate safety, tolerability, pharmacokinetics, and pharmacodynamics of PF-06817024 in healthy volunteers, in participants with chronic rhinosinusitis, with nasal polyps and in participants with moderate-to-severe Atopic Dermatitis
Study identification
- NCT ID
- NCT02743871
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- 97 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 27, 2016 (Actual)
- Primary completion
- Mar 9, 2021 (Actual)
- Completion
- Mar 9, 2021 (Actual)
- Last update posted
- May 19, 2022
2016 – 2021
United States locations
- U.S. sites
- 20
- U.S. states
- 11
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UC Davis Dermatology | Sacramento | California | 95816 | — |
| UC Davis CTSC Clinical Research Center | Sacramento | California | 95817 | — |
| UC Davis Health | Sacramento | California | 95817 | — |
| New Haven Clinical Research Unit | New Haven | Connecticut | 06511 | — |
| Dermatology Physicians of Connecticut | Shelton | Connecticut | 06484 | — |
| ForCare Clinical Research | Tampa | Florida | 33613 | — |
| Dawes Fretzin Clinical Research Group, LLC | Indianapolis | Indiana | 46256 | — |
| Dawes Fretzin Dermatology Group, LLC | Indianapolis | Indiana | 46256 | — |
| The Indiana Clinical Trials Center | Plainfield | Indiana | 46168 | — |
| Academic Dermatology | Edina | Minnesota | 55435 | — |
| Clinical Research Institute, Inc. | Minneapolis | Minnesota | 55402 | — |
| Ear, Nose & Throat Specialty Care of Minnesota, P.A. | Minneapolis | Minnesota | 55404 | — |
| Prism Research, LLC | Saint Paul | Minnesota | 55114 | — |
| Hassman Research Institute | Berlin | New Jersey | 08009 | — |
| Carolina Phase 1 Research, LLC | Raleigh | North Carolina | 27612 | — |
| Vital Prospects Clinical Research Institute, PC | Tulsa | Oklahoma | 74136 | — |
| Health Concepts | Rapid City | South Dakota | 57702 | — |
| Lee Medical Associates, PA | San Antonio | Texas | 78213 | — |
| Progressive Clinical Research, PA | San Antonio | Texas | 78213 | — |
| Virginia Clinical Research, Inc. | Norfolk | Virginia | 23502 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02743871, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 19, 2022 · Synced Oct 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02743871 live on ClinicalTrials.gov.